PureTech Health

PureTech Health (PureTech Health plc, PRTC.L) is an interdisciplinary biopharmaceutical company dedicated to developing 21st-century medicines that modulate adaptive human systems. Their therapies target the immune, nervous, and gastrointestinal systems, addressing the underlying pathophysiology of diseases from a systemic perspective rather than through a single receptor or pathway. They are advancing over 20 clinical studies, including multiple human proof-of-concept studies and pivotal or registration studies, with readouts expected within the next two years. PureTech Health has collaborated with some of the world’s leading scientific experts to develop a rich and evolving R&D pipeline. Together with PureTech, their experienced team and board analyze more than 650 scientific discoveries each year to identify and advance what they believe to be the most promising opportunities for patients. This team and process position PureTech Health at the forefront of breakthrough scientific innovation, leading the company beyond and between existing disciplines.